A form of efficacy for a mixing device comprising a single central device number covered by an adhesive and an enteral coating

摘要

The utility model relates to a multi unit medicinal material composed of a core, wherein the core is composed of a plurality of units, each unit includes an active pharmaceutical principle, each unit includes an adhesive material, and the multi unit medicinal material also includes, A coating of the core In addition, this multi unit drug is used in the treatment of inflammation, especially in the intestinal tract. Claim 2: the multi unit pharmaceutical form described in claim 1,The coating (b) with the characteristic of core includes an additional coating (B2),Additional cladding (B2) between core (A) and outer cladding (B1),The additional coating (B2) comprises a polymer soluble in intestinal or gastric juice, selected from the group, consisting of at least partially neutralized polycarbonate polymer and a non-ionic polymer, each combined with at least one polymer. Additive selected from inducer and / or base and mixture. 44. Claim 4: the multi unit pharmaceutical form referred to in any of the above claims is characterized by the presence of at least one adhesive (A2) containing Shiite or alejanato,preferentemente chitos n Reivindicaci n 12 La forma farmac utica unitaria m ltiple de acuerdo con cualquiera de las reivindicaciones 1 a 11 caracterizada porque el principio activo para uso farmac utico (a1) se selecciona de metronidazol vancomicina cido 5-amino-salic lico budesonida y anti